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Summary
A provider-assisted, counseling-based, pediatric HIV disclosure model was developed and 
implemented at two tertiary-care hospitals in Bangkok, Thailand. All undisclosed perinatally 
acquired HIV-infected children, ages 7–18 years, and their caretakers were offered the four-step 
disclosure service, including: screening, readiness assessments and preparation, disclosure 
sessions, and follow-up evaluations. To assess psychosocial outcomes of disclosure, we compared 
the scores of the Children Depression Inventory and the PedsQL 4.0™ at baseline and at 2-month 
and 6-month follow-up visits, and compared the scores of the Child Behavioral Checklist at 
baseline and at 6-month follow-up. Disclosure was made to 186 children, 160 of whom completed 
post-disclosure assessments. The median Children’s Depression Inventory score in 135 children 
decreased significantly from 11 at baseline to 8 at 2-month and 6-month follow-up (p < 0.01). The 
median PedsQL 4.0™ scores in 126 children increased significantly from 78 at baseline to 80 at 2-
month and 84 at 6-month follow-up (p = 0.04). The median Child Behavioral Checklist scores 
were not significantly changed. In conclusion, pediatric HIV diagnosis disclosure using this model 
was found to have positive effect on the children’s mood and quality of life, and no negative effect 
on children’s behaviours. This disclosure program should be expanded to improve psychosocial 
health of HIV-infected children.
Keywords
HIV; pediatric; disclosure; psychosocial; outcomes; Thailand
Reprints and permissions: sagepub.co.uk/journalsPermissions.nav
Corresponding author: Vitharon Boon-yasidhi, Division of Child and Adolescent Psychiatry, Department of Pediatrics, Faculty of 
Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. vitharon.boo@mahidol.ac.th. 
Disclaimer
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US 
Centers for Disease Control and Prevention.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
HHS Public Access
Author manuscript
Int J STD AIDS. Author manuscript; available in PMC 2016 March 01.
Published in final edited form as:










With increased availability of highly active anti-retroviral therapy, increasing numbers of 
children with perinatally-acquired HIV infection are surviving into adolescence and 
adulthood. Disclosure of HIV diagnosis to these children is presently one of the clinical 
challenges for caretakers and healthcare providers. The American Academy of Pediatrics 
recommends that school-aged children and adolescents living with HIV should be told about 
their diagnosis.1 Adolescents, particularly, should be fully informed about their HIV status 
in order to maximise their involvement in care and to reduce the risk of virus transmission 
through sexual behaviours.2,3
Despite this recommendation, it was found that a substantial proportion of HIV-infected 
children world-wide had not been made fully aware of their HIV diagnosis.4 Clinical reports 
from western countries, as well as from Thailand, suggest that caretakers have a number of 
reasons for not disclosing HIV diagnosis to their infected children, including concerns that 
children are too young to understand or to keep the diagnosis secret, and fears that children 
might be psychologically harmed by the disclosure.5
Studies on the effects of HIV diagnosis disclosure on HIV-infected children are limited and 
reveal mixed results. Bachanas et al.6 found that HIV-infected children who had not been 
told their diagnosis tend to report more psychological distress than children who knew that 
they have HIV disease. On the other hand, New et al.7 found that children who were aware 
of their HIV diagnosis were more likely to have internalising behavioural problems. Other 
studies, however, found no association between disclosure and psychosocial outcomes.8,9 
The variation of the results might be in part due to the difference in the population and study 
method of these studies.
As specific disclosure guidelines are lacking and data on disclosure outcomes are limited, 
starting in 2005 a group of multidisciplinary professionals involved in HIV care at Siriraj 
Hospital, Queen Sirikit National Institute for Child Health (QSNICH), and the Thailand 
MOPH-US CDC Collaboration developed a provider-assisted pediatric HIV disclosure 
model and implemented the model at the two hospitals (Siriraj and QSNICH). The model 
program provides counseling to caretakers to assess their readiness for and preparing them 
for the disclosure process. We recently reported the development and the evaluation of the 
model.10 It was found that the model was feasible to implement, and beneficial for 
healthcare providers to use as a guideline on supporting HIV-infected children and their 
caretakers. The aim of this study was to assess the changes in psychosocial status in the 
children after disclosure. We hypothesised that disclosure by this model would not be 
associated with negative psychological outcomes, as measured by standardised instruments 
for children’s behaviours, mood, and health-related quality of life.
Methods
Study design and population
This was an observational prospective cohort study to evaluate psychosocial outcomes in 
children after their HIV diagnosis was disclosed to them. Between February 2005 and 
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December 2008, all caretakers of perinatally HIV-infected children aged 7–18 years who 
were receiving treatment at either of the two pediatric HIV treatment centers (Siriraj 
Hospital and QSNICH) and unaware of their HIV status were offered the HIV diagnosis 
disclosure service. Exclusion criteria included children with severe cognitive impairment, 
psychosis, suicidality, or urgent medical conditions, and caretakers with severe medical or 
psychiatric conditions that would interfere with participation in the program.
The disclosure model
The disclosure model is a counseling-based model that guides healthcare providers to assist 
caretakers in disclosing HIV status to infected children, providing HIVrelated health 
information to children and caretakers, and supporting children’s emotional reactions related 
to disclosure. The model comprises four steps as outlined in Figure 1.
The first step of the model involves screening HIV-infected children and their caretakers for 
eligibility and offering disclosure counseling service to the caretakers. In the step of 
readiness assessment (step 2), counselors interview caretakers separately from their child 
following the program guidelines. The guidelines are written as a manual with clear 
instruction how to conduct counseling (available online at www.cqihiv.com/
ViewDocumentDetail.aspx?ID = 3&Title=Pediatric HIV Disclosure Manual). In this step, 
counselors explore caretakers’ attitudes, fears, and perceptions on benefits and 
disadvantages regarding disclosure. Through the counseling process, counselors work with 
caretakers to determine the caretaker’s and the child’s readiness. A caretaker was considered 
ready if the caretaker (a) perceived that their child was ready and (b) had made the decision 
to disclose the child’s HIV diagnosis to the child. Counselors and caretakers had to agree on 
the child’s readiness upon review of the child’s clinical and psychosocial status, including 
developmental level and ability to communicate. If it is determined that both caretakers and 
children are ready,10 a provider-assisted disclosure session (step 3) is scheduled. Caretakers 
may choose to disclose at home prior to coming to the disclosure session. If caretakers or 
children are not ready, further assessment and counseling is provided.
In the disclosure session (step 3), children are scheduled to have their HIV status disclosed, 
either by counselors or by caretakers in the presence of counselors. Children are counseled 
about medication adherence, prevention of virus transmission, and confidentiality of 
diagnosis. Counselors facilitate communication between caretakers and children. In step 4, 
children and caretakers are assessed for outcomes related to disclosure at 2 - and 6-month 
follow-up visits.
Instruments
Child behavioural checklist—The Child Behavioural Checklist (CBCL) is a parent-
reported instrument designed to identify problem behaviours in children and adolescents. 
Originally developed by Achenbach, this instrument has been translated into many 
languages and widely used in clinical studies.11 The present study used the school age form 
(for ages 4–18 years), which has been translated into Thai and validated in Thai children.12 
The Thai version contains 118 problem items of the original CBCL plus additional 24 items. 
These items inquire about behavioural and emotional symptoms over the past 6 months, 
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with scores ranging from 0 to 2 (0 = none, 1 = occasional, and 2 = frequent). The total scores 
are categorised into “normal”, “problem”, and “clinical” ranges. For children aged 6–11 
years, “problem” ranges are total scores of 49–66 in boys and 48–65 in girls; and “clinical” 
ranges are above 66 in boys and above 65 in girls. For children aged 12 and older of both 
genders, scores of 42–57 and above 57 are considered “problem”, and “clinical” ranges, 
respectively.12 In this study, the CBCL was administered at baseline (in the step 2 of the 
model) and at 6-month post-disclosure follow-up.
Children’s depression inventory—The Children’s Depression Inventory (CDI), 
developed by Kovacs, is a widely-used rating scale for assessing depressive symptoms in 
children and adolescents aged 7–17 years.13 The CDI consists of 27 self-reported items. 
Each item is scored from 0 to 2 (0 = no, 1 = often, and 2 = always) for severity of depressive 
symptoms in the preceding two weeks, with total scores ranging from 0 to 52. The Thai 
version of CDI was developed and validated by Trangkasombat and Likanapichitkul.14 A 
score of 15 and above was found to be an optimal cut-off in identifying depression, with a 
sensitivity of 78.9% and specificity of 91.3%, as compared to psychiatric interview.14 In this 
study, the children completed the CDI at baseline, and at 2-month and 6-month post-
disclosure follow-up.
The PedsQL 4.0™ Generic Core Scales—The PedsQL 4.0™ Generic Core Scales is 
an instrument for assessing health-related quality of life in children and adolescents.15 It 
consists of 23 items representing four domains: Physical Functioning, Emotional 
Functioning, Social Functioning, and School Functioning, and is composed of parallel child 
self-report and parent proxy-report formats. Each item is scored from 0 (never a problem) to 
4 (almost always a problem). Items are reverse-scored and linearly transformed to a 0–100 
scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, and 4 = 0), so that higher scores indicate better 
HRQOL. The PedsQL 4.0™ Generic Core Scales has been translated into many languages 
including Thai. It has been widely used in a variety of chronic diseases including HIV-
infected children and adolescents.16 In this study, the child self-report versions for ages 5–7, 
8–12, and 13– 18 years were used and data were collected at baseline, and at 2-month and 6-
month post-disclosure follow-up.
Evaluation
To assess the disclosure outcome by this model, we analysed data from children who were 
determined eligible between February 2005 and December 2008 and had follow-up data 
through June 2009. Medical records and counseling notes were abstracted for demographic 
and clinical data.
Data analysis
Data were entered into an MS Access database, and descriptive data were analysed using 
SPSS Statistics 17.0 and Stata 12. Non-parametric tests were used for analysis. Median 
scores for CDI and PedsQL 4.0™ at baseline and at 2-month and 6-month post-disclosure 
follow-up were compared by using the Friedman test. We only analysed results with 
complete data for all three time points. Median scores for CBCL at baseline and at 6-month 
post-disclosure visit were compared by using the Wilcoxon signed rank test. The differences 
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in proportion of CBCL at baseline and at 6-month post-disclosure follow-up were compared 
by marginal homogeneity Chi square test and those of CDI at baseline, 2-month, and 6-
month post-disclosure follow-up were compared by Cochran test.
Human subjects protections
Data were collected by clinic staff as part of routine services at both hospitals. Human 
subjects research ethics approval for the project was obtained from the US Centers for 
Disease Control and Prevention IRB, and the research ethic review committees of the two 
hospitals.
Results
Of 438 children who were screened (step 1), 398 (91%) were eligible for disclosure. Forty 
(9%) children were not eligible due to a lack of informed consent, having conditions that 
precluded effective communication, or having had their HIV status disclosed to them prior 
to screening. Readiness assessment (step 2) was completed in 353/398 (91%) caretakers of 
the eligible children. Forty-five caretakers did not undergo readiness assessment because the 
children were referred to other hospitals (n = 18), died (n = 5), lost to follow-up (n = 1), or 
had not yet been scheduled for assessment at the time of this analysis (n = 21). Of those who 
underwent readiness assessment, 216/353 (61%) were determined to be ready for disclosure. 
Disclosure (step 3) was provided to 186/216 (86%) children. The time spent for the 
assessment and preparation, measured between the points of eligibility screening and 
disclosure, ranged from 0 to 49 months, with a mean of 15.2 months. The remaining 30 
children were awaiting disclosure appointments at the time of this analysis. Post-disclosure 
assessment (step 4) was completed for 160/186 (86%) children; these data were included in 
this analysis (Figure 1).
Of the 160 children for whom all steps were completed, the mean age (±SD) of the children 
was 11.8 (±1.9) years, and 60% were women. Sixty-seven percent of the children were cared 
for by someone other than a biological parent, and were living in households with extended 
family. Demographic and clinical characteristics of the children are shown in Table 1.
Changes in psychological outcomes
There were no significant changes in the median CBCL scores at baseline and at 6-month 
post-disclosure follow-up (n = 129, p = 0.58). The median CDI scores were decreased 
slightly, but significantly, from 11 at baseline to 8 at 2-month and 6-month post-disclosure 
follow-up (n = 135, p = 0.001). The total PedsQL 4.0™ scores were increased from 78 at 
baseline to 80 at 2-month, and 84 at 6-month post-disclosure follow-up (n = 126, p = 0.039) 
(Figure 2).
The percentage of the children who scored in the clinical range of CBCL decreased from 22 
at baseline to 17 at 6-month post-disclosure follow-up, but this decrease was not significant 
(p = 0.550). The percentage of children who had CDI scores in the depressive range was 
also decreased but not significantly changed after disclosure (p = 0.323) (Figure 3).
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When the scores in each domain of the PedsQL 4.0™ at baseline and at 2-month and 6-
month post-disclosure follow-up were compared, it was found that only the Social 
Functioning domain scores were significantly increased after disclosure (p = 0.003), while 
other domain scores were not significantly changed (Figure 4).
Discussion
This study assessed psychosocial outcomes in perinatally HIV-infected children whose HIV 
diagnoses were disclosed to them through a provider-assisted paediatric HIV disclosure 
model. We found no changes in children’s behavioural problems, a slight but significant 
decrease in children’s depression level, and an increase in children’s Social Functioning 
quality of life scores after disclosure.
The findings from this study confirm the results of our previous study indicating that there 
were no negative outcomes in children’s emotional and behavioural status after disclosure.10 
While some of the previous studies reported higher emotional problems associated with 
disclosure; for instance, New and colleagues reported that children who were told their HIV 
status had higher internalising problem behaviors as compared to non-disclosed children;7 
other studies reported lower6 or not different behavioural problem scores among disclosed 
as compared to non-disclosed children.17,18 A recent large study by Santamaria et al.19 
revealed that HIV-infected youth who had been told their diagnosis did not show an increase 
of emotional problem. All of these previous studies were retrospective or cross-sectional in 
nature comparing between the group of disclosed and non-disclosed children. The present 
study, however, was a prospective cohort which allowed us to systematically compare 
psychological status before and after disclosure in same subjects. The results of this study, 
therefore, provide stronger evidence to support the hypothesis that disclosure (with 
systematic preparation), when carefully done, does not cause a negative psychological 
impact on the children.
Besides measuring problem behaviours and depressed mood, we also measured health-
related quality of life of these children. Health-related quality of life measures have been 
increasingly used to assess children and caregiver perspectives of health and functioning in 
many chronic health conditions including HIV infection.16 However, there have been few 
studies examining the effect of disclosure on quality of life of HIV-infected children. A 
prospective cohort study by Butler et al.20 quality of life scores were found not to be 
affected by disclosure. The findings from our study confirm that disclosure of HIV status to 
child using this model can be accomplished with no negative impact on children’s quality of 
life, and also demonstrate a significant increase in the total scores and the Social 
Functioning domain scores of the PedsQL 4.0™ after disclosure. We found, however, that 
the children in this cohort had lowest scores in the School Functioning domain. This 
suggests that interventions to improve school functioning are needed for these children.
The present study has some limitations which may affect interpretation of the results. First, 
positive outcomes found in the study may be due to selection bias related to good 
relationships between the clinicians and the children and caretakers who received long-term 
services in the clinics. Second, this study was conducted in only perinatally acquired HIV-
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infected children, and disclosure was done through a model that emphasises preparing 
caregivers and supporting the children and caretakers. The results found in this study may 
not apply to children who acquired HIV by other routes or who may be disclosed without 
preparation. Third, there were no data in non-disclosed children available for comparison. 
Fourth, we did not assess the children’s psychological status beyond the period of 6 months 
after disclosure.
Despite these limitations, the findings from this study add to evidence that HIV status 
disclosure with systematic preparation can be accomplished without negative impact on 
children’s psychosocial status, and may positively affect children’s mood and quality of life. 
Trainings for this disclosure model have been organised for over 600 public healthcare 
providers from 90 hospitals throughout Thailand, and also for professionals from neighbor 
countries including Indonesia, Malaysia, Myanmar, and Vietnam.
Conclusions
We found that disclosure of HIV diagnosis to perinatally acquired HIV-infected children 
with this provider-assisted paediatric disclosure model had no negative psychosocial effect 
on the children, and may reduce depression and improve quality of life. This disclosure 
model enables healthcare providers to confidently help children and caretakers with HIV 
disclosure, which is one of the critical steps in the comprehensive treatment of HIV-infected 
children.
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Disclosure algorithm and number of children participating in the disclosure program and 
received psychometric assessments, Bangkok, Thailand, 2005–2009.
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Changes in CBCL, CDI, and PedQL 4.0™ median scores before and after disclosure.
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Changes in the percentages of children who scored in each category of CBCL and CDI after 
disclosure.
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Changes in the scores of each domain of PedQL 4.0™ after disclosure.
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Table 1
Characteristics of children who received HIV diagnosis disclosure and completed pre- and post-disclosure 
assessments.
Characteristicsa
Age at disclosure: mean ± SD (years) 11.8 ± 1.9
Gender: N (%)
  Female 111 (60)
  Male 75 (40)
Caregivers: N (%)
  Father and/or mother 53 (33)
  Someone other than a biological parent 107 (67)
Family structure: N (%)
  Single 41(16)
  Extended 101 (63)
  Foster 16 (10)
Immunologic classification: N (%)
  CD4 ≥ 25% 41 (26)
  CD4 15–24% 67 (42)
  CD4 < 15% 50 (32)
aNot include missing data.
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